
Northern Exposure PR
We are the leading public relations company serving the life science, pharmaceutical and technology industries.Northern Exposure is the leading public relations company serving the life science, pharmaceutical and technology industries.
Twenty years experience maximising clients’ media exposure and advising on subjects from press handling, marketing strategy and reputation management
Northern Exposure Public Relations is uniquely skilled in assisting clients in all public relations requirements
Meet Our Team

Richard Kerns
Managing Director
Richard has twenty five years’ experience working with life science companies and organisations around the globe, both independently and within larger agencies.

Edward Dutton
Vice President
Ed has over fifteen years experience of working within the pharmaceutical industry, both as a laboratory chemist and in sales and marketing roles within contract research organisations, contract manufacturers and technology based companies.

Sarah Houlton
Technical Consultant in Residence
Sarah has a degree and PhD in chemistry from Imperial College London, and worked as a drug discovery chemist in the pharmaceutical industry. As a science journalist, she has been writing about the pharmaceutical, biotech and chemical industries for more than twenty years.
Our Services
NEPR can assist clients in numerous manners, either on a retained agency basis or through project work around events. Activities include:
Planning & research, web content creation, media relations, technical articles, thought leadership articles, trade show and event management and support, social media, product launches, crisis management & more.
Contact us today to find out how we can assist you
Our Clients




Client News
02/06/2020 Catalent Appoints Charles Lickfold as Chief Information Officer
03/06/2020 Vectura Expands Business Development Team with Three Global Appointments
15/06/2020 Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
18/06/2020 Cambrex Names Thomas Loewald as Chief Executive Officer
22/06/2020 Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
01/07/2020 Cambrex Increases Flexible Manufacturing Capacity at Karlskoga, Sweden Facility
01/07/2020 Catalent Completes Purchase of Pharmaceutical Packaging Facility in Shiga, Japan
17/07/2020 SGS’s Quality, Expertise & Reliability Recognized at CRO Leadership Awards 2020
04/08/2020 Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
01/10/2020 Catalent Launches OneXpress™ Solution to Accelerate Oral Dosage Products from Clinic to Launch
01/10/2020 Catalent Wins Scottish Engineering Vice President Award for Excellence
12/10/2020 Cambrex Completes Major Expansion of Solid Form Screening Facility in Edinburgh
29/10/2020 Catalent to Acquire Cell Therapy Manufacturing Facility from Bone Therapeutics
05/11/2020 Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent
18/11/2020 SGS Increases its Capacity for Human Challenge Studies
30/11/2020 SGS Welcomes First Participants onto COVID-19 Clinical Trials in US
03/12/2020 Catalent to Invest $10 Million to Expand High Potency Containment Capabilities For Micronization
07/12/2020 Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
17/12/2020 Vectura earns $11m milestone as Hikma receives US FDA approval for generic Advair Diskus®
Upcoming Events
NEPR will be attending the following events:
